About this Journal Submit a Manuscript Table of Contents
International Journal of Biomaterials
Volume 2013 (2013), Article ID 949460, 10 pages
http://dx.doi.org/10.1155/2013/949460
Research Article

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model

1Department of Urology, Ankara Training and Research Hospital, Ulucanlar, 06340 Ankara, Turkey
2Department of Gastroenterology, Turkiye Yuksek Ihtisas Training and Research Hospital, Sihhiye, 06100 Ankara, Turkey
3Institute of Materials Science and Nanotechnology, National Nanotechnology Research Center (UNAM), Bilkent University, 06800 Ankara, Turkey
4Department of Pathology, Ankara Training and Research Hospital, Ulucanlar, 06340 Ankara, Turkey
5Department of Biochemistry, Fatih University Medical School, 06560 Ankara, Turkey
6Department of Hematology, Hacettepe University Medical School, Sihhiye, 06100 Ankara, Turkey

Received 30 October 2012; Revised 13 December 2012; Accepted 20 January 2013

Academic Editor: Thomas J. Webster

Copyright © 2013 Emre Huri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Ellis-Behnke, “At the nanoscale: nanohemostat, a new class of hemostatic agent,” Wiley Interdisciplinary Reviews, vol. 3, no. 1, pp. 70–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. G. Ellis-Behnke, Y. X. Liang, D. K. C. Tay et al., “Nano hemostat solution: immediate hemostasis at the nanoscale,” Nanomedicine, vol. 2, no. 4, pp. 207–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Hartgerink, E. Beniash, and S. I. Stupp, “Self-assembly and mineralization of peptide-amphiphile nanofibers,” Science, vol. 294, no. 5547, pp. 1684–1688, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. D. Hartgerink, E. Beniash, and S. I. Stupp, “Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 8, pp. 5133–5138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. L. Niece, J. D. Hartgerink, J. J. J. M. Donners, and S. I. Stupp, “Self-assembly combining two bioactive peptide-amphiphile molecules into nanofibers by electrostatic attraction,” Journal of the American Chemical Society, vol. 125, no. 24, pp. 7146–7147, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Toksoz, R. Mammadov, A. B. Tekinay, and M. O. Guler, “Electrostatic effects on nanofiber formation of self-assembling peptide amphiphiles,” Journal of Colloid and Interface Science, vol. 356, no. 1, pp. 131–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Mammadov, B. Mammadov, S. Toksoz, et al., “Heparin mimetic peptide nanofibers promote angiogenesis,” Biomacromolecules, vol. 12, pp. 3508–3519, 2011.
  8. G. A. Silva, C. Czeisler, K. L. Niece et al., “Selective differentiation of neural progenitor cells by high-epitope density nanofibers,” Science, vol. 303, no. 5662, pp. 1352–1355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. N. Shah, N. A. Shah, M. M. D. R. Lim, C. Hsieh, G. Nuber, and S. I. Stupp, “Supramolecular design of self-assembling nanofibers for cartilage regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3293–3298, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Mata, Y. Geng, K. J. Henrikson et al., “Bone regeneration mediated by biomimetic mineralization of a nanofiber matrix,” Biomaterials, vol. 31, no. 23, pp. 6004–6012, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Rajangam, H. A. Behanna, M. J. Hui et al., “Heparin binding nanostructures to promote growth of blood vessels,” Nano Letters, vol. 6, no. 9, pp. 2086–2090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bulut, T. S. Erkal, S. Toksoz, A. B. Tekinay, T. Tekinay, and M. O. Guler, “Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers,” Biomacromolecules, vol. 12, pp. 3007–3014, 2011.
  13. W. Cordier and V. Steenkamp, “Herbal remedies affecting coagulation: a review,” Pharmaceutical Biology, vol. 50, pp. 443–452, 2012.
  14. Y. Beyazit, M. Kekilli, I. C. Haznedaroglu, et al., “Ankaferd hemostat in the management of gastrointestinal hemorrhages,” World Journal of Gastroenterology, vol. 17, pp. 3962–3970, 2011.
  15. Y. Beyazit, M. Kurt, M. Kekilli, H. Goker, and I. C. Haznedaroglu, “Evaluation of hemostatic effects of Ankerferd as an alternative medicine,” Alternative Medicine Review, vol. 15, no. 4, pp. 329–336, 2010. View at Scopus
  16. B. Z. Haznedaroglu, Y. Beyazit, S. L. Walker, et al., “Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat,” Critical Reviews in Oncology/Hematology, vol. 83, pp. 21–34, 2012.
  17. H. Goker, I. C. Haznedaroglu, S. Ercetin, et al., “Haemostatic actions of the folkloric medicinal plant extract, Ankaferd Blood Stopper,” Blood, vol. 110, pp. 53b–53b, 2007.
  18. H. Goker, I. C. Haznedaroglu, S. Ercetin et al., “Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper,” Journal of International Medical Research, vol. 36, no. 1, pp. 163–170, 2008. View at Scopus
  19. G. Ak, O. Cakir, H. O. Kazancioglu, et al., “The use of a new hemostatic agent: Ankaferd Blood Stopper in hemophiliacs,” Haemophilia, vol. 16, article 51, 2010.
  20. D. O. Demiralp, N. Igci, B. Ayhan, et al., “Pro-hemostatic and anti-thrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses,” Clinical and Applied Thrombosis/Hemostasis, 2012. View at Publisher · View at Google Scholar
  21. B. Z. Haznedaroglu, I. C. Haznedaroglu, S. L. Walker et al., “Ultrastructural and morphological analyses of the in vitro and in vivo hemostatic effects of Ankaferd Blood Stopper,” Clinical and Applied Thrombosis/Hemostasis, vol. 16, no. 4, pp. 446–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. I. C. Haznedaroglu, “Molecular basis of the pleiotropic effects of Ankaferd Blood Stopper,” IUBMB Life, vol. 61, article 290, 2009.
  23. D. O. Demiralp, I. C. Haznedaroglu, and N. Akar, “Functional proteomic analysis of Ankaferd Blood Stopper,” Turkish Journal of Hematology, vol. 27, no. 2, pp. 71–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Yilmaz, S. Gulec, D. Torun, et al., “The effects of Ankaferd (R) Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile,” Turkish Journal of Hematology, vol. 28, pp. 276–285, 2011.
  25. B. Al, C. Yildirim, M. Cavdar, S. Zengin, H. Buyukaslan, and M. E. Kalender, “Effectiveness of Ankaferd Blood Stopper in the topical control of active bleeding due to cutaneous-subcutaneous incisions,” Saudi Medical Journal, vol. 30, no. 12, pp. 1520–1525, 2009. View at Scopus
  26. O. S. Balcik, M. Koroglu, H. Cipil, et al., “A placebo-controlled, randomized, double-blinded, cross-over phase I clinical study to demonstrate safety of Ankaferd Blood Stopper topical usage in healthy volunteers,” International Journal of Laboratory Hematology, vol. 32, supplement 1, pp. 126–127, 2010.
  27. Y. Beyazit, T. Kart, A. Kuscu, et al., “Successful management of bleeding after dental procedures with application of blood stopper: a single center prospective trial,” Journal of Contemporary Dental Practice, vol. 12, pp. 379–384, 2011.
  28. I. Iynen, F. Bozkus, I. San, et al., “The hemostatic efficacy of Ankaferd Blood Stopper in adenoidectomy,” International Journal of Pediatric Otorhinolaryngology, vol. 75, pp. 1292–1295, 2011.
  29. A. Karaman, M. Baskol, S. Gursoy, et al., “Endoscopic topical application of Ankaferd Blood Stopper in gastrointestinal bleeding,” Journal of Alternative and Complementary Medicine, vol. 18, pp. 65–68, 2012.
  30. A. M. Teker, A. Y. Korkut, O. Gedikli, and V. Kahya, “Prospective, controlled clinical trial of Ankaferd Blood Stopper in children undergoing tonsillectomy,” International Journal of Pediatric Otorhinolaryngology, vol. 73, no. 12, pp. 1742–1745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Teker, A. Y. Korkut, V. Kahya, and O. Gedikli, “Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis,” European Archives of Oto-Rhino-Laryngology, vol. 267, no. 9, pp. 1377–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Huri, T. Akgul, A. Ayyildiz, H. Üstün, and C. Germiyanoǧlu, “Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial,” Journal of Urology, vol. 181, no. 5, pp. 2349–2354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Huri, K. T. Akgul, M. O. Yucel, et al., “The second step in vitro trial of Ankaferd (R) Blood Stopper (R): comparison with other hemostatic agents,” Turkish Journal of Medical Sciences, vol. 41, pp. 7–15, 2011.
  34. E. Huri, T. Akgul, A. Ayyildiz, M. Baǧcioǧlu, and C. Germiyanoǧlu, “First clinical experience of Ankaferd Blood Stopper as a hemostatic agent in partial nephrectomy,” Kaohsiung Journal of Medical Sciences, vol. 26, no. 9, pp. 493–495, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Huri, T. Akgul, O. Yucel, et al., “The second step in vitro trial of Ankaferd Blood Stopper: comparison with the other hemostatic agents, glubran 2, floseal and celox,” Journal of Endourology, vol. 23, pp. A189–A189, 2009.
  36. N. Akkoc, M. Akcelik, I. C. Haznedaroglu, et al., “In vitro anti-bacterial activities of Ankaferd medicinal plant extract,” Türkiye Klinikleri, vol. 29, pp. 410–415, 2009.
  37. N. Tasdelen Fisgin, Y. Tanriverdi Cayci, A. Y. Coban et al., “Antimicrobial activity of plant extract Ankaferd Blood Stopper,” Fitoterapia, vol. 80, no. 1, pp. 48–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Saribas, B. Sener, I. C. Haznedaroglu, G. Hascelik, S. Kirazli, and H. Goker, “Antimicrobial activity of Ankaferd Blood Stopper against nosocomial bacterial pathogens,” Central European Journal of Medicine, vol. 5, no. 2, pp. 198–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. A. M. Teker, A. Y. Korkut, V. Kahya, and O. Gedikli, “Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis,” European Archives of Oto-Rhino-Laryngology, vol. 267, no. 9, pp. 1377–1381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yasar and H. Ozkul, “Haemostatic effect of Ankaferd Blood Stopper (r) seen during adenoidectomy,” The African Journal of Traditional, Complementary and Alternative Medicines, vol. 8, pp. 444–446, 2011.
  41. M. Guler, G. Maralcan, S. Kul, et al., “The efficacy of Ankaferd Blood Stopper for the management of bleeding following total thyroidectomy,” Journal of Investigative Surgery, vol. 24, pp. 205–210, 2011.
  42. A. T. Ulus, N. N. Turan, S. Ozyalcin, et al., “Surgical and histopathological effects of topical Ankaferd (R) hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure,” Turkish Journal of Hematology, vol. 28, pp. 206–212, 2011.
  43. O. Kandemir, M. Buyukates, N. O. Kandemir et al., “Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model,” Journal of Cardiothoracic Surgery, vol. 5, no. 1, article 110, 2010. View at Publisher · View at Google Scholar · View at Scopus